Biocon’s Alzumab Is Priced At Half Of Its Rival Brands, But Will It Change The Game?
This article was originally published in PharmAsia News
Executive Summary
The Indian drug manufacturer has taken a giant leap with the launch of its indigenously researched psoriasis treatment. But experts suggest the task to establish it against larger products will be extremely daunting.